XML 17 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 49,060 $ 187,026
Investments in marketable securities 309,502 143,325
Accounts receivable 9,464 1,304
Inventories 4,623 3,416
Prepaid expenses and other current assets 19,316 4,993
Total current assets 391,965 340,064
Property and equipment, less accumulated depreciation of $12,515 and $12,495 at December 31, 2017 and 2016, respectively 9,062 9,816
In-process research & development 23,000 486,700
Goodwill 197,797 197,797
Other non-current assets 5,200 2,468
Total Assets 627,024 1,036,845
Current liabilities:    
Accounts payable, accrued expenses, and other current liabilities 53,890 41,008
Deferred reimbursements, current portion 7,750 13,850
Contingent consideration payable, current portion 8,400 56,101
Total current liabilities 70,040 110,959
Deferred reimbursements 14,156 21,906
Convertible notes 164,167 154,464
Contingent consideration payable 17,000 213,621
Deferred income taxes 6,465 173,771
Other non-current liability 2,346 1,973
Commitments and contingencies
Stockholders' equity:    
Common stock, $.01 par value, 250,000,000 shares authorized, 166,989,790 shares issued and outstanding at December 31, 2017 Common stock, $.01 par value, 250,000,000 shares authorized, 142,691,986 shares issued and outstanding at December 31, 2016 1,721 1,480
Additional paid-in capital 1,400,758 1,120,156
Accumulated other comprehensive loss:    
Foreign currency translation adjustment (1,659) 1,945
Unrealized gain/(loss) on available-for securities (436) 102
Warrants 16,076 16,076
Accumulated deficit (1,063,610) (779,608)
Total stockholders' equity 352,850 360,151
Total Liabilities and Stockholders' Equity $ 627,024 $ 1,036,845